CLINICAL_TRIALS
trial_result
· 2021-09-16
Clinical Trial Update: Post-Marketing Surveillance Study of Aripiprazole in Patients With Autism
Summary
Post-marketing surveillance study of aripiprazole in patients with autism has completed and results were posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Autism | Status: COMPLETED | Results posted: 2021-09-16